Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Preclinical drug studies in MEN1-related neuroendocrine neoplasms (MEN1-NENs).

Journal article

Grozinsky-Glasberg S. et al, (2020), Endocrine-related cancer, 27, R345 - R355

Effects of epigenetic pathway inhibitors on corticotroph tumour AtT20 cells

Journal article

Lines KE. et al, (2020), Endocrine-Related Cancer, 27, 163 - 174

Organizational Innovation for Developing New Medicines That Target Aging and Age-Related Conditions.

Journal article

Ford GA. et al, (2020), The journals of gerontology. Series A, Biological sciences and medical sciences, 75, 87 - 88

A Chemical Probe for Tudor Domain Protein Spindlin1 to Investigate Chromatin Function

Journal article

Fagan V. et al, (2019), Journal of Medicinal Chemistry, 62, 9008 - 9025

A genetics-led approach defines the drug target landscape of 30 immune-related traits

Journal article

Fang H. et al, (2019), Nature Genetics, 51, 1082 - 1091

ANGIOTENSIN 2 TYPE 2 RECEPTOR BLOCKADE IS A NOVEL TARGET FOR MURINE OSTEOARTHRITIS PAIN

Conference paper

von Loga IS. et al, (2019), OSTEOARTHRITIS AND CARTILAGE, 27, S420 - S421

An Activity‐Based Probe Targeting Non‐Catalytic, Highly Conserved Amino Acid Residues within Bromodomains

Journal article

D'Ascenzio M. et al, (2019), Angewandte Chemie International Edition, 58, 1007 - 1012

Design, Synthesis and Characterization of Covalent KDM5 Inhibitors

Journal article

Vazquez‐Rodriguez S. et al, (2019), Angewandte Chemie International Edition, 58, 515 - 519

Donated chemical probes for open science

Journal article

Müller S. et al, (2018), eLife, 7

BROMODOMAIN INHIBITORS ARE POTENT EPIGENETIC REGULATORS OF CATABOLIC GENE EXPRESSION IN HUMAN OSTEOARTHRITIC CHONDROCYTES

Conference paper

de Andres MC. et al, (2018), OSTEOARTHRITIS AND CARTILAGE, 26, S154 - S154

Therapeutics discovery: From bench to first in-human trials*

Journal article

Al-Hujaily E. et al, (2018), Biomedical Reports

Open innovation in neuroscience research and drug discovery

Journal article

Hunter AJ. et al, (2018), Brain and Neuroscience Advances, 2, 239821281879927 - 239821281879927

Assessing histone demethylase inhibitors in cells: lessons learned

Journal article

Hatch SB. et al, (2017), Epigenetics & Chromatin, 10

Maximising value from a United Kingdom Biomedical Research Centre: study protocol

Journal article

Greenhalgh T. et al, (2017), Health Research Policy and Systems, 15

Establishing a reliable framework for harnessing the creative power of the scientific crowd

Journal article

Carter AJ. et al, (2017), PLOS Biology, 15, e2001387 - e2001387

Load More